German health insurance regulator directs centres to report commercial CAR-T treatments to EBMT

(European Society for Blood and Marrow Transplantation) The G-BA published its directions on the treatment of German patients with CAR T-cell therapies. According to the decision, beside structural and qualification requirements, the treating facilities must report patients to the German Register for Stem Cell Transplantation (DRST), the Pediatric Register for Stem Cell Transplantation (PRST) or the European Society for Blood and Marrow Transplantation (EBMT) Registry. Reporting data is a condit...